Wikidata

(Q39748114)

English

Empagliflozin, via Switching Metabolism Toward Lipid Utilization, Moderately Increases LDL Cholesterol Levels Through Reduced LDL Catabolism

scientific article

In more languages

Statements

title
Empagliflozin, via Switching Metabolism Toward Lipid Utilization, Moderately Increases LDL Cholesterol Levels Through Reduced LDL Catabolism (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
27207551
retrieved
14 September 2017
author name string
François Briand
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
27207551
retrieved
14 September 2017
Eric Mayoux
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
27207551
retrieved
14 September 2017
Emmanuel Brousseau
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
27207551
retrieved
14 September 2017
Noémie Burr
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
27207551
retrieved
14 September 2017
Isabelle Urbain
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
27207551
retrieved
14 September 2017
Clément Costard
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
27207551
retrieved
14 September 2017
Michael Mark
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
27207551
retrieved
14 September 2017
Thierry Sulpice
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
27207551
retrieved
14 September 2017
publication date
5 April 2016
1 reference
stated in
Europe PubMed Central
PubMed ID
27207551
retrieved
14 September 2017
page(s)
2032-2038
1 reference
stated in
Europe PubMed Central
PubMed ID
27207551
retrieved
14 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q39748114&oldid=2089292839"